Arthritis Medications - DMARDs, NSAIDs, JAK Inhibitors

Arthritis is not one disease but an umbrella term for over 100 conditions that affect joints, surrounding tissues, and overall mobility. The two most common forms are osteoarthritis (OA), a wear-and-tear degeneration of joint cartilage affecting more than 500 million people worldwide, and rheumatoid arthritis (RA), an autoimmune disease where the body immune system attacks the synovial lining of joints. Gout, psoriatic arthritis, ankylosing spondylitis, and juvenile idiopathic arthritis round out the major categories.

Arthritis affects roughly 1 in 5 adults in industrialised countries and is the leading cause of work disability globally. Pain, morning stiffness, joint swelling, reduced range of motion, and progressive functional decline are common features. Without treatment, severe forms can lead to permanent joint deformity, cardiovascular complications, and significant reduction in life expectancy — particularly in untreated RA.

The good news: modern pharmacotherapy has transformed arthritis from a slowly disabling condition to one that can be controlled and often pushed into remission. The catalogue below covers the full spectrum — from over-the-counter pain relief for occasional joint discomfort to disease-modifying anti-rheumatic drugs (DMARDs) and biologic agents that halt joint destruction.

🦴 Conditions This Category Treats

Osteoarthritis is the most common form, caused by progressive cartilage loss in weight-bearing joints (knees, hips, spine) and small joints of the hands. Risk factors include age, obesity, prior joint injury, repetitive occupational stress, and genetic predisposition. Symptoms include activity-related pain that improves with rest, brief morning stiffness (under 30 minutes), and crepitus (grating sensation) on joint movement. Hand OA often produces Heberden and Bouchard nodes — bony enlargements at finger joints.

Rheumatoid arthritis is a systemic autoimmune disease that affects roughly 1% of the population, with women three times more likely to develop it than men. It causes symmetric inflammation of small joints (hands, wrists, feet), prolonged morning stiffness (over an hour), fatigue, low-grade fever, and over time can damage the cardiovascular system, lungs, eyes, and skin. Early signs include persistent swelling in the small finger joints (MCP, PIP joints) and a positive rheumatoid factor or anti-CCP antibody on blood tests.

Gout results from monosodium urate crystal deposition in joints, classically causing severe acute pain at the first metatarsophalangeal joint (big toe). It affects roughly 4% of adults, especially men over 40 and post-menopausal women. Psoriatic arthritis affects up to 30% of patients with psoriasis and can damage joints, nails, and entheses (where tendons attach to bone). Ankylosing spondylitis primarily affects the spine and sacroiliac joints, causing progressive stiffness in young adults. Juvenile idiopathic arthritis covers arthritis subtypes that begin before age 16 and requires paediatric-rheumatology expertise.

💊 How Modern Arthritis Treatment Works

Treatment strategy depends entirely on the type of arthritis. For osteoarthritis, the foundation remains weight management, exercise, and symptom control with paracetamol, topical NSAIDs (Voltaren gel), oral NSAIDs (Mobic, Celebrex, Indocin), and intra-articular corticosteroid injections. Severe end-stage OA may require joint replacement surgery. Glucosamine and chondroitin remain controversial — some patients report benefit despite mixed trial data.

For rheumatoid arthritis, the cornerstone is disease-modifying anti-rheumatic drugs (DMARDs) — conventional synthetic agents like methotrexate, hydroxychloroquine (Plaquenil), and sulfasalazine. Methotrexate at low weekly doses remains the anchor of RA treatment globally because it slows joint damage, is well-studied, and is inexpensive. When conventional DMARDs are insufficient, modern biologic DMARDs (TNF inhibitors, IL-6 inhibitors, JAK inhibitors) can induce remission in patients who previously faced inevitable decline.

For gout, treatment is split into acute attacks and long-term prevention. Acute attacks respond to NSAIDs (Indocin), colchicine (Colcrys), or oral corticosteroids within hours. Long-term urate-lowering therapy with allopurinol (Zyloprim) or febuxostat (Adenuric) prevents recurrent attacks and tophaceous deposits when started gradually after the acute phase resolves. Target serum urate is below 6 mg/dL (360 micromol/L).

💊 Drug Classes in This Category

✅ How to Choose the Right Arthritis Treatment

• 🦴 Mild osteoarthritis (knee, hand) → topical NSAID gel (Voltaren Gel) first-line. Less systemic toxicity than oral options.
• 🥕 Moderate osteoarthritis with daily pain → oral NSAID — Mobic (meloxicam) for once-daily dosing or Celebrex if GI ulcer risk is elevated.
• 🌉 Rheumatoid arthritis (newly diagnosed) → refer to rheumatologist urgently for methotrexate-based DMARD therapy. Use NSAIDs as bridge for symptom relief only.
• 🪥 Acute gout attack (red, hot, painful big toe) → Indocin or Colcrys (colchicine) within 24 hours. Earlier intervention = faster relief.
• 🏃 Recurrent gout (2+ attacks per year) → long-term Zyloprim (allopurinol) or Adenuric (febuxostat). Start at low dose 2-4 weeks AFTER acute attack resolves.
• 🤰 Pregnancy → avoid NSAIDs (especially third trimester — ductal closure risk). Paracetamol is first-line. Hydroxychloroquine is among the safest DMARDs in pregnancy.
• 👨‍🏻‍⚔️ Older adults → minimise NSAIDs (GI bleed, AKI, hypertension risk). Topical NSAIDs, paracetamol, and physical therapy form the foundation.

❓ Frequently Asked Questions about Arthritis

• What is the difference between osteoarthritis and rheumatoid arthritis?

  Osteoarthritis is mechanical — cartilage wears down over time, affects weight-bearing joints (knees, hips, spine, hands), worsens with activity, and morning stiffness lasts under 30 minutes. Rheumatoid arthritis is autoimmune — the immune system attacks joint linings, causes symmetric inflammation in small joints (hands, wrists, feet), prolonged morning stiffness over an hour, fatigue, and systemic symptoms. RA requires DMARDs; OA does not.

• Are NSAIDs safe for daily use?

  Daily NSAIDs carry meaningful risks: GI ulcers and bleeding, hypertension, fluid retention, kidney impairment, and increased cardiovascular events. For occasional flares, short courses are reasonable. For chronic use, prefer the lowest dose, add a proton pump inhibitor, monitor kidney function and blood pressure, and consider COX-2 selective options like Celebrex if GI risk dominates.

• Does glucosamine actually work for osteoarthritis?

  Evidence is mixed. Large trials show modest or no benefit on average, but some individual patients clearly respond. Glucosamine sulfate 1500 mg daily is well-tolerated and has a reasonable safety profile. A 3-month trial is reasonable if you wish to test it; stop if no benefit at that point. Diabetics should monitor blood glucose; shellfish-allergic individuals should look for vegetarian-source glucosamine.

• Can diet help with gout?

  Yes. Reducing purine-rich foods (organ meats, anchovies, sardines, mussels, beer) and fructose-sweetened drinks lowers serum urate modestly. Weight loss, moderate dairy intake, coffee, and cherries are associated with fewer attacks. Diet alone is rarely sufficient for established gout; pharmacotherapy is usually needed alongside lifestyle changes.

• How long until methotrexate works for RA?

  Methotrexate (the anchor RA drug) typically begins working at 4-8 weeks with full effect by 12 weeks. The starting dose is usually 7.5-10 mg once weekly, escalated to 15-25 mg weekly. Folic acid 5 mg weekly (taken 24 hours after the methotrexate dose) reduces side effects without compromising efficacy. Never take methotrexate daily — that dose schedule is for cancer chemotherapy and causes severe toxicity in RA-dose patients.

• Should I exercise if I have arthritis?

  Absolutely yes. Regular low-impact exercise reduces pain and improves function in both OA and RA, even during flares. Walking, swimming, cycling, tai chi, and resistance training are best. Avoid prolonged immobility — "use it or lose it" applies powerfully to arthritic joints. A physiotherapist can tailor a programme to your specific joint involvement.

🩺 When to See a Healthcare Provider

Seek prompt rheumatology referral for: symmetric joint swelling lasting over 6 weeks (possible RA — early treatment changes outcomes), red hot painful joint with fever (rule out septic arthritis or crystal arthritis), back pain with morning stiffness in young adults (possible ankylosing spondylitis), or arthritis with psoriasis or inflammatory bowel disease. RA carries higher cardiovascular and infection risk, so routine monitoring is essential.

Inform your prescriber about all current medications (NSAIDs interact with anticoagulants, lithium, methotrexate; allopurinol interacts with azathioprine), kidney and liver disease, history of GI ulcers, cardiovascular disease, and pregnancy plans. DMARDs and biologics require specialist supervision with baseline screening for hepatitis B/C, tuberculosis, and vaccination updates before initiation.

📚 Related Articles

• 📖 Understanding Rheumatoid Arthritis: Causes, Symptoms, and Treatment
• 📖 Joint Fire: How to Stop Rheumatoid Arthritis Before It Spreads
• 📖 Moderate-to-Severe Rheumatoid Arthritis: Advanced Clinical Framework
• 📖 Periarthritis: When Joint Support Structures Become Inflamed
• 📖 Osteochondrosis: Restoring Mobility and Breaking the Pain Cycle
• 🔗 Browse all RXshop articles